The role of somatostatin analogs in the treatment of endocrine gastrointestinal tumors.
Trautmann
M E
ME
Department of Internal Medicine, Phillips-University, Marburg, Germany.
Neuhaus
C
C
Lenze
H
H
Benning
R
R
Benning
M
M
Dennler
H J
HJ
Bruns
C
C
Joseph
K
K
Arnold
R
R
D014408:Biomarkers, Tumor / Q000032:analysis; D015408:Gastrinoma / Q000188:drug therapy / Q000473:pathology; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005935:Glucagonoma / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D007340:Insulinoma / Q000188:drug therapy / Q000473:pathology; D008303:Malignant Carcinoid Syndrome / Q000188:drug therapy / Q000473:pathology; D015282:Octreotide / Q000627:therapeutic use*; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D017481:Receptors, Somatostatin / Q000032:analysis; D003969:Vipoma / Q000188:drug therapy / Q000473:pathology
D014408:Biomarkers, Tumor; D017481:Receptors, Somatostatin; D015282:Octreotide